Dimerization of Tie2 mediated by its membrane-proximal FNIII domains
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Significance: Tie2 is a receptor tyrosine kinase with important roles in vascular development. Inhibiting Tie2 may impair tumor angiogenesis, whereas activating Tie2 may be beneficial in sepsis and inflammation. To modulate Tie2 therapeutically, it is essential to understand its regulation. Although it is known how Tie2 binds its activating ligands (angiopoietins), it is not clear how this binding (or Tie1 interactions) regulates the receptor. Here, we show that the previously unstudied Tie2 extracellular membrane-proximal region engages in receptor–receptor contacts crucial for Tie2 activation. Our data suggest that angiopoietins promote receptor clustering, utilizing Tie2–Tie2 interactions mediated by key fibronectin III domains, a unique mode of RTK activation. Blocking these Tie2–Tie2 interactions may have therapeutic value in cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, the model of the dimeric ANGPT2147–496 in complex with the inactive, half-bent α5β1-integrin and TIE2 ECDs could be created without steric clashes while maintaining the overall geometry and interactions of the existing structures found in this study and previously (13, 16, 54–56) (Figure 8, A and B, and Supplemental Video 2).”
From Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling (2026) · cites this paper as [54]
Citations
Cites
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Self-citationDali server: conservation mapping in 3D
Holm, L., & Rosenstr�m, P. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq366 · Cited by 3,640
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570 · cited 1×
“Similarly, although Ang2 can activate Tie2 expressed in NIH 3T3 cells, this ligand instead functions as an antagonist or partial agonist in endothelial cells and in vivo (9, 16, 17).”
BackgroundSvergun, D., Barberato, C., & Koch, M. H. J. (1995) · Journal of Applied Crystallography · doi:10.1107/s0021889895007047 · Cited by 3,434
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,847
DAMMIF , a program for rapid ab-initio shape determination in small-angle scattering
Franke, D., & Svergun, D. I. (2009) · Journal of Applied Crystallography · doi:10.1107/s0021889809000338 · Cited by 2,021
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81812-7 · Cited by 1,989 · cited 1×
“T Tie family [named as “tyrosine kinases with immunoglobulin and EGF homology domains” (1)] of receptor tyrosine kinases (RTKs) contains two members, Tie1 and Tie2/ TEK, that are expressed primarily on endothelial cells and control cellular responses to the angiopoietin (Ang) ligands (2, 3).”
BackgroundControl of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
Augustin, H. G., Young Koh, G., Thurston, G., & Alitalo, K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2639 · Cited by 1,465 · cited 2×
“Tie1 and Tie2 play important roles in the development of normal vasculature, in vascular homeostasis, and in angiogenesis (4, 5).”
BackgroundAutomated matching of high- and low-resolution structural models
Kozin, M. B., & Svergun, D. I. (2001) · Journal of Applied Crystallography · doi:10.1107/s0021889800014126 · Cited by 1,302
Lemke, G. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009076 · Cited by 598 · cited 1×
“It will be interesting to determine whether the analogous FNIII domains in the Tyro/Axl/Mer family (43) have similar self-association functions.”
Background
Cited by
Therapeutic targeting of the angiopoietin–TIE pathway
Saharinen, P., Eklund, L., & Alitalo, K. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.278 · Cited by 620
Angiopoietin-1 is required for Schlemm’s canal development in mice and humans
Thomson, B. R., Souma, T., Tompson, S. W., Onay, T., Kizhatil, K., Siggs, O. M., Feng, L., Whisenhunt, K. N., Yanovitch, T. L., Kalaydjieva, L., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci95545 · Cited by 171
Context-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP
Souma, T., Thomson, B. R., Heinen, S., Anna Carota, I., Yamaguchi, S., Onay, T., Liu, P., Ghosh, A. K., Li, C., Eremina, V., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714446115 · Cited by 135
“Higher oligomerization status is required to cluster the TIE2 receptors in cis and elicit downstream signaling cascades due to the relatively large “physical” distance between them, as characterized by the wide angular conformational structure on cell membrane (39, 48).”
BackgroundStructural basis of Tie2 activation and Tie2/Tie1 heterodimerization
Leppänen, V.-M., Saharinen, P., & Alitalo, K. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616166114 · Cited by 127
“Freely available online through the PNAS open access option.”
BackgroundMethodInfluentialLAG3 ectodomain structure reveals functional interfaces for ligand and antibody recognition
Ming, Q., Celias, D. P., Wu, C., Cole, A. R., Singh, S., Mason, C. C., Dong, S., Tran, T. H., Amarasinghe, G. K., Ruffell, B., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01238-7 · Cited by 99
The Tie2 signaling pathway in retinal vascular diseases: a novel therapeutic target in the eye
Nguyen, Q. D., Heier, J. S., Diana, V., Mirando, A. C., Pandey, N. B., Sheng, H., & Heah, T. (2020) · International Journal of Retina and Vitreous · doi:10.1186/s40942-020-00250-z · Cited by 80
Ang-1 and VEGF: central regulators of angiogenesis
Zhao, Y., Yu, B., Wang, Y., Tan, S., Xu, Q., Wang, Z., Zhou, K., Liu, H., Ren, Z., & Jiang, Z. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05010-3 · Cited by 59
Khan, K. A., Wu, F. T. H., Cruz‐Muñoz, W., & Kerbel, R. S. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.201708253 · Cited by 56
“(B) In the absence of ligands, Tie 2 can form inactive dimers through the membrane-proximal Fn 3 fibronectin type III domain (Lepp € anen et al, 2017 ; Moore et al, 2017 ).”
Characterization of ANGPT2 mutations associated with primary lymphedema
Leppänen, V.-M., Brouillard, P., Korhonen, E. A., Sipilä, T., Jha, S. K., Revencu, N., Labarque, V., Fastré, E., Schlögel, M., Ravoet, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax8013 · Cited by 49
“Our present SAXS results in combination with the previously published crystal structures and TIE2 clustering schemes (54, 55) allow validation of the N-terminally truncated ANGPT-TIE interactions.”
BackgroundMethodResultInfluentialInsulin and epidermal growth factor receptor family members share parallel activation mechanisms
Ferguson, K. M., Hu, C., & Lemmon, M. A. (2020) · Protein Science · doi:10.1002/pro.3871 · Cited by 41
Self-citationF-domain valency determines outcome of signaling through the angiopoietin pathway
Zhao, Y. T., Fallas, J. A., Saini, S., Ueda, G., Somasundaram, L., Zhou, Z., Raj, I. X., Ehnes, D. D., Xu, C., Carter, L. P., et al. (2021) · EMBO Reports · doi:10.15252/embr.202153471 · Cited by 39
“…FNIII domains (Souma et al , 2016; Lepp € anen et al , 2017; Moore et al , 2017), and it has been proposed that binding of multivalent Ang1-like ligands leads to the generation of a regular lattice of Tie2 receptors from constitutively formed dimers (Lepp € anen et al , 2017; Moore et al , 2017).”
Anti-angiogenic Targets: Angiopoietin and Angiopoietin Receptors
Kiss, E. A., & Saharinen, P. (2019) · Springer eBooks · doi:10.1007/978-3-319-33673-2_4 · Cited by 32
Jo, G., Bae, J., Hong, H. J., Han, A. R., Kim, D.-K., Hong, S. P., Kim, J. A., Lee, S., Koh, G. Y., & Kim, H. M. (2021) · Nature Communications · doi:10.1038/s41467-021-26620-1 · Cited by 32
Li, X., Martinez-Ledesma, E., Zhang, C., Gao, F., Zheng, S., Ding, J., Wu, S., Nguyen, N., Clifford, S. C., Wen, P. Y., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0325 · Cited by 27
Identification of specific Tie2 cleavage sites and therapeutic modulation in experimental sepsis
Idowu, T. O., Etzrodt, V., Seeliger, B., Bolaños-Palmieri, P., Thamm, K., Haller, H. G., & David, S. (2020) · eLife · doi:10.7554/elife.59520 · Cited by 24
Role of Angiopoietin/Tie2 System in Sepsis: A Potential Therapeutic Target
Chi, Y., Yu, S., Jia, Y., Liu, D., Zhuo, M., & Li, X. (2024) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296241238010 · Cited by 30
“31 At quiescence state, Ang-1 binds to the ectodomain of Tie2 in a trans-con fi guration to induce its activation.”
BackgroundShan, Y., Si, R., Wang, J., Zhang, Q., Zhou, H., Zhang, J., Zhang, J., & Chen, Q. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.12.067 · Cited by 18
Qiao, Y., Chen, Y., Tan, C., Sun, X., Chen, X., & Chen, J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.764509 · Cited by 22
“…type III (FNIII) domains of Tie2 (PDB ID: 5UTK, 438-741 aa) and Tie2 kinase domain (PDB: 1FVR, 798-1124 aa) were used as templates Frontiers in Genetics | www.frontiersin.org December 2021 | Volume 12 | Article 7645092 for respective missense variants (Moore et al., 2017) (Shewchuk et al., 2000).”
BackgroundMethodUpdate Overview of the Role of Angiopoietins in Lung Cancer
Tsakogiannis, D., Nikolakopoulou, A., Zagouri, F., Stratakos, G., Syrigos, K., Zografos, E., Koulouris, N. G., & Bletsa, G. (2021) · Medicina · doi:10.3390/medicina57111191 · Cited by 21
Tumor Angiogenesis: A Key Target for Cancer Therapy
(2019) · Springer eBooks · doi:10.1007/978-3-319-33673-2 · Cited by 15
Zhu, J., Li, J., Chung, C.-S., Lomas-Neira, J. L., & Ayala, A. (2021) · Shock · doi:10.1097/shk.0000000000001902 · Cited by 7
Development of an Orthogonal Tie2 Ligand Resistant to Inhibition by Ang2
Issa, E., Moss, A. J., Fischer, M., Kang, M., Ahmed, S., Farah, H., Bate, N., Giakomidi, D., & Brindle, N. P. J. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00409 · Cited by 8
Hollander, M. J., Malaker, S. A., Riley, N. M., Perez, I., Abney, N. M., Gray, M. A., Maxson, J. E., Cochran, J. R., & Bertozzi, C. R. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104755 · Cited by 5
“(2023) 299(6) 104755 dependent manner; however, an alternative ligandindependent mechanism was shown to be mediated by membrane-proximal FnIII domains (36).”
BackgroundAnti-angiogenic Targets: Angiopoietin and Angiopoietin-Receptors
Kiss, E. A., & Saharinen, P. (2017) · Springer eBooks · doi:10.1007/978-3-319-31215-6_4-1 · Cited by 11
“In the dimeric TIE2 the LBDs were located far apart, facilitating TIE2 activation by multimeric but not dimeric angiopoietins (Leppanen et al. 2017; Moore et al. 2017).”
BackgroundHuang, Q., Zhang, K., Li, Y., Gan, F., Tang, X., & Tang, B. (2022) · Applied and Environmental Microbiology · doi:10.1128/aem.01503-22 · Cited by 2
“Two possible dimerization modes have been proposed for tyrosine kinase Tie2: the dimer 1 interface primarily involves loops in the boundary region of FnIII domains, while dimer 2 is mediated entirely by contacts between two FnIII domains of two protomers in a manner similar to that of irisin (48).”
BackgroundSong, Q., Zhang, F., Yuan, T., & Wei, Y. (2021) · European Cytokine Network · doi:10.1684/ecn.2021.0468 · Cited by 2
“Tie2 is encoded by TEK (or CD202b) gene and is regulated directly by multimeric angiopoietin (Ang) ligands [9].”
BackgroundStructural organization of TAM receptor ectodomains
Starbird, C. A., Zuo, Y., Walker, K., Stayrook, S. E., & Ferguson, K. M. (2026) · Biochemical Journal · doi:10.1042/bcj20260584 · Cited by 1
“We and others have previously shown that the membrane-proximal FNIII domains of TIE2 mediate ligand-independent dimerization [20,21].”
Self-citationInactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling
Sipilä, T., Ponna, S. K., Venkatesha Murthy, A., Pink, A., Enkavi, G., Bohra, S. K., Lewna, K., Ganesh, K., Liu, Q., Korhonen, M., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci190552
“…α 5 Calf1-2 were used. the inactive, half-bent α 5 β 1 -integrin and TIE2 ECDs could be created without steric clashes while maintaining the overall geometry and interactions of the existing structures found in this study and previously (13, 16, 54–56) (Figure 8, A and B, and Supplemental Video 2).”
InfluentialMutational screens highlight glycosylation as a modulator of CSF3R activityPreprint
Hollander, M. J., Malaker, S. A., Perez, I., Maxson, J. E., Cochran, J. R., & Bertozzi, C. R. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.01.502088
Receptor Tyrosine Kinases and Their Ligands
Ferguson, K. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00226-1
Self-citation
Metadata
- Authors
- Moore, J. O., Lemmon, M. A., & Ferguson, K. M.
- Affiliations
- University of Pennsylvania (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2017-04-10
- Volume
- 114
- Issue
- 17
- Pages
- 4382-4387
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5410832
- OpenAlex
- W2606533043
- Cited by
- 30
- References
- 49
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 7 · 2020: 4 · 2019: 3 · 2018: 3 · 2017: 4
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- HHS | NIH | National Cancer Institute (R03-CA187021)
- HHS | NIH | National Institute of General Medical Sciences (R01-GM099891, R01-GM107435)
- American Cancer Society (123704-PF-13-034-01-DMC)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- Tie2, receptor dimerization, fibronectin type III domain, angiopoietin-1, receptor activation, Tie1, receptor tyrosine kinase, angiogenesis, tumor angiogenesis, receptor oligomerization, crystal structure
- MeSH terms
- Protein Domains, Animals, Cell Membrane, Humans, Models, Molecular, Mutation, Protein Conformation, X-Ray Diffraction, NIH 3T3 Cells, Receptor, TIE-2, Mice, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.